Kusajili – Clinical trials directory

Result of your search per sponsor: Merck Farma y Química, S.A

Woman and Man Max 99 years
Merck Farma y Química, S.A Update Il y a 4 ans

An exploratory pharmacogenomic study of cetuximab monotherapy in patients with metastatic EGFR-Positive colorectal carcinoma To explore whether Muc 2, Muc 3, CFTR, SERPINB-5, BMP-2, BTC, TLN2, EPHA1, HMGCoA or Spondin expression can predict response to CETUXIMAB treatment.

Country None
organs None
Specialty None

unknown

More information